Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia
Clinical trial NCT00544999 · UNKNOWN
Trial details
- NCT number
- NCT00544999
- Sponsor
- Institut de Recherche Clinique sur les Cancers et le Sang
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-04-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.